• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-L-锁核酸修饰的反义寡核苷酸在体外诱导有效的剪接调控。

Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In Vitro.

作者信息

Raguraman Prithi, Wang Tao, Ma Lixia, Jørgensen Per Trolle, Wengel Jesper, Veedu Rakesh N

机构信息

Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth 6150 Australia.

Perron Institute for Neurological and translational Science, Perth 6005, Australia.

出版信息

Int J Mol Sci. 2020 Mar 31;21(7):2434. doi: 10.3390/ijms21072434.

DOI:10.3390/ijms21072434
PMID:32244535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7177859/
Abstract

Alpha-l-Locked nucleic acid (α-l-LNA) is a stereoisomeric analogue of locked nucleic acid (LNA), which possesses excellent biophysical properties and also exhibits high target binding affinity to complementary oligonucleotide sequences and resistance to nuclease degradations. Therefore, α-l-LNA nucleotides could be utilised to develop stable antisense oligonucleotides (AO), which can be truncated without compromising the integrity and efficacy of the AO. In this study, we explored the potential of α-l-LNA nucleotides-modified antisense oligonucleotides to modulate splicing by inducing exon-23 skipping in mouse myoblasts in vitro. For this purpose, we have synthesised and systematically evaluated the efficacy of α-l-LNA-modified 2'-O-methyl phosphorothioate (2'-OMePS) AOs of three different sizes including 20mer, 18mer and 16mer AOs in parallel to fully-modified 2'-OMePS control AOs. Our results demonstrated that the 18mer and 16mer truncated AO variants showed slightly better exon-skipping efficacy when compared with the fully-23 modified 2'-OMePS control AOs, in addition to showing low cytotoxicity. As there was no previous report on using α-l-LNA-modified AOs in splice modulation, we firmly believe that this initial study could be beneficial to further explore and expand the scope of α-l-LNA-modified AO therapeutic molecules.

摘要

α-L-锁核酸(α-l-LNA)是锁核酸(LNA)的立体异构类似物,它具有优异的生物物理性质,对互补寡核苷酸序列也表现出高靶标结合亲和力以及对核酸酶降解的抗性。因此,α-l-LNA核苷酸可用于开发稳定的反义寡核苷酸(AO),其可以被截短而不损害AO的完整性和功效。在本研究中,我们探讨了α-l-LNA核苷酸修饰的反义寡核苷酸在体外诱导小鼠成肌细胞中外显子23跳跃以调节剪接的潜力。为此,我们合成并系统评估了三种不同大小(包括20聚体、18聚体和16聚体AO)的α-l-LNA修饰的2'-O-甲基硫代磷酸酯(2'-OMePS)AO与完全修饰的2'-OMePS对照AO的功效。我们的结果表明,与完全修饰的2'-OMePS对照AO相比,18聚体和16聚体截短的AO变体显示出略好的外显子跳跃功效,此外还显示出低细胞毒性。由于之前没有关于使用α-l-LNA修饰的AO进行剪接调节的报道,我们坚信这项初步研究可能有助于进一步探索和扩大α-l-LNA修饰的AO治疗分子的范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/c5f9d3efc243/ijms-21-02434-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/f714db7c257c/ijms-21-02434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/4c0229ef42d6/ijms-21-02434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/b1e243a214b3/ijms-21-02434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/0b2f2f3ca593/ijms-21-02434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/95002a8dfe99/ijms-21-02434-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/6a18354cb683/ijms-21-02434-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/c5f9d3efc243/ijms-21-02434-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/f714db7c257c/ijms-21-02434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/4c0229ef42d6/ijms-21-02434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/b1e243a214b3/ijms-21-02434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/0b2f2f3ca593/ijms-21-02434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/95002a8dfe99/ijms-21-02434-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/6a18354cb683/ijms-21-02434-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/7177859/c5f9d3efc243/ijms-21-02434-g007.jpg

相似文献

1
Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In Vitro.α-L-锁核酸修饰的反义寡核苷酸在体外诱导有效的剪接调控。
Int J Mol Sci. 2020 Mar 31;21(7):2434. doi: 10.3390/ijms21072434.
2
Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro.体外系统评价 2'-氟修饰嵌合反义寡核苷酸介导的外显子跳跃。
Sci Rep. 2019 Apr 15;9(1):6078. doi: 10.1038/s41598-019-42523-0.
3
Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2'-O-methyl RNA mixmer antisense oligonucleotides for exon skipping in vitro.体外评估脱水己糖醇核酸、环己烯基核酸和d-阿卓糖醇核酸修饰的2'-O-甲基RNA混合mer反义寡核苷酸用于外显子跳跃。
Chem Commun (Camb). 2016 Nov 10;52(92):13467-13470. doi: 10.1039/c6cc07447b.
4
Rational Design of Short Locked Nucleic Acid-Modified 2'-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In Vitro.用于高效体外外显子跳跃的短锁核酸修饰的2'-O-甲基反义寡核苷酸的合理设计
Mol Ther Nucleic Acids. 2017 Dec 15;9:155-161. doi: 10.1016/j.omtn.2017.09.002. Epub 2017 Sep 12.
5
Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2'-O-Methyl Mixmer Antisense Oligonucleotide.吗啉代核酸(MNA)-尿苷亚磷酰胺的合成,以及使用MNA/2'-O-甲基混合体反义寡核苷酸进行外显子跳跃
Molecules. 2016 Nov 22;21(11):1582. doi: 10.3390/molecules21111582.
6
On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.关于四种锁核酸核苷酸掺入抗H-Ras反义寡核苷酸后的体外和体内性质
Chembiochem. 2005 Jun;6(6):1104-9. doi: 10.1002/cbic.200400419.
7
Optimizing RNA/ENA chimeric antisense oligonucleotides using in vitro splicing.利用体外剪接优化RNA/ENA嵌合反义寡核苷酸
Methods Mol Biol. 2012;867:131-41. doi: 10.1007/978-1-61779-767-5_9.
8
Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA.用α-L-锁核酸扩展反义寡核苷酸的设计视野。
Nucleic Acids Res. 2003 Nov 1;31(21):6365-72. doi: 10.1093/nar/gkg820.
9
Free-radical ring closure to conformationally locked α-L-carba-LNAs and synthesis of their oligos: nuclease stability, target RNA specificity, and elicitation of RNase H.自由基环合形成构象锁定的α-L-卡巴-LNAs 及其寡聚物的合成:核酸酶稳定性、靶 RNA 特异性和诱导 RNase H。
J Org Chem. 2010 Sep 17;75(18):6122-40. doi: 10.1021/jo100900v.
10
Intramuscular Evaluation of Chimeric Locked Nucleic Acid/2'Methyl-Modified Antisense Oligonucleotides for Targeted Exon 23 Skipping in Mdx Mice.嵌合型锁核酸/2'-甲基修饰反义寡核苷酸在mdx小鼠中靶向外显子23跳跃的肌肉内评估
Pharmaceuticals (Basel). 2021 Oct 30;14(11):1113. doi: 10.3390/ph14111113.

引用本文的文献

1
Evaluation of Chemically Modified Nucleic Acid Analogues for Splice Switching Application.用于剪接转换应用的化学修饰核酸类似物的评估。
ACS Omega. 2023 Dec 11;8(51):48650-48661. doi: 10.1021/acsomega.3c07618. eCollection 2023 Dec 26.
2
Splice-Switching Antisense Oligonucleotides Targeting Extra- and Intracellular Domains of Epidermal Growth Factor Receptor in Cancer Cells.靶向癌细胞中表皮生长因子受体胞外和胞内结构域的剪接转换反义寡核苷酸
Biomedicines. 2023 Dec 13;11(12):3299. doi: 10.3390/biomedicines11123299.
3
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation.

本文引用的文献

1
Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro.体外系统评价 2'-氟修饰嵌合反义寡核苷酸介导的外显子跳跃。
Sci Rep. 2019 Apr 15;9(1):6078. doi: 10.1038/s41598-019-42523-0.
2
Systematic Screening of Commonly Used Commercial Transfection Reagents towards Efficient Transfection of Single-Stranded Oligonucleotides.常用商业转染试剂对单链寡核苷酸高效转染的系统筛选。
Molecules. 2018 Oct 8;23(10):2564. doi: 10.3390/molecules23102564.
3
Rational Design of Short Locked Nucleic Acid-Modified 2'-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In Vitro.
反义寡核苷酸介导的剪接转换:减轻癌症的潜在治疗方法。
Cancers (Basel). 2021 Nov 5;13(21):5555. doi: 10.3390/cancers13215555.
4
Beyond ribose and phosphate: Selected nucleic acid modifications for structure-function investigations and therapeutic applications.超越核糖与磷酸:用于结构功能研究及治疗应用的特定核酸修饰
Beilstein J Org Chem. 2021 Apr 28;17:908-931. doi: 10.3762/bjoc.17.76. eCollection 2021.
用于高效体外外显子跳跃的短锁核酸修饰的2'-O-甲基反义寡核苷酸的合理设计
Mol Ther Nucleic Acids. 2017 Dec 15;9:155-161. doi: 10.1016/j.omtn.2017.09.002. Epub 2017 Sep 12.
4
Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2'-O-Methyl Mixmer Antisense Oligonucleotide.吗啉代核酸(MNA)-尿苷亚磷酰胺的合成,以及使用MNA/2'-O-甲基混合体反义寡核苷酸进行外显子跳跃
Molecules. 2016 Nov 22;21(11):1582. doi: 10.3390/molecules21111582.
5
Eteplirsen: First Global Approval.依替膦酸酶:全球首次获批。
Drugs. 2016 Nov;76(17):1699-1704. doi: 10.1007/s40265-016-0657-1.
6
Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2'-O-methyl RNA mixmer antisense oligonucleotides for exon skipping in vitro.体外评估脱水己糖醇核酸、环己烯基核酸和d-阿卓糖醇核酸修饰的2'-O-甲基RNA混合mer反义寡核苷酸用于外显子跳跃。
Chem Commun (Camb). 2016 Nov 10;52(92):13467-13470. doi: 10.1039/c6cc07447b.
7
Exon skipping therapy for Duchenne muscular dystrophy.外显子跳跃疗法治疗杜氏肌营养不良症。
Adv Drug Deliv Rev. 2015 Jun 29;87:104-7. doi: 10.1016/j.addr.2015.05.008. Epub 2015 May 14.
8
Improvement of a streptavidin-binding aptamer by LNA- and α-l-LNA-substitutions.通过锁核酸(LNA)和α-L-锁核酸(α-l-LNA)取代改进链霉亲和素结合适体
Bioorg Med Chem Lett. 2014 May 15;24(10):2273-7. doi: 10.1016/j.bmcl.2014.03.082. Epub 2014 Apr 3.
9
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches.杜氏肌营养不良症的治疗:基因方法带来新的希望。
Nat Rev Genet. 2013 Jun;14(6):373-8. doi: 10.1038/nrg3460. Epub 2013 Apr 23.
10
Replacing the 2'-oxygen with an exocyclic methylene group reverses the stabilization effects of α-L-LNA.用环外亚甲基取代 2'-氧,会使α-L-LNA 的稳定化作用发生反转。
Bioorg Med Chem Lett. 2011 Jan 1;21(1):588-91. doi: 10.1016/j.bmcl.2010.10.025. Epub 2010 Oct 14.